Cancer

News

Sanofi snaps up Synthorx for $2.5bn, eyeing cancer immunothe...

Sanofi has agreed to buy cancer drugs firm Synthorx for around $2.5 billion, aiming to strengthen its immune-oncology drug pipeline and creating the possibility of new combination therapies

News

App helps cancer patients manage their meds

A healthcare app due to launch at the end of this year aims to empower cancer patients and improve survival outcomes by allowing patients to better manage their medications and care.

Events

HW191105 World ADC London banner design 740 X 400px

Partner Content

World ADC London 2020

Maximise the Therapeutic Index of Your ADC Pipeline

News

FDA grants AZ's Imfinzi fast review in new lung cancer use

The FDA has granted AstraZeneca’s Imfinzi immunotherapy a faster six-month review in patients with extensive-stage small cell lung cancer.

News

Merck & Co's Keytruda shows promise with prostate cancer 'su...

A small proportion of men with advanced prostate cancer, who have exhausted all other treatment options, were ‘super responders’ to Merck & Co’s Keytruda (pembrolizumab) immunotherapy i

News

Conservatives shy away from drug price debate in election ma...

The Conservative Party has pledged to encourage R&D in the UK’s life science industry should it win the December general election, with its manifesto shying away from the measures to cr

Sanofi snaps up Synthorx for $2.5bn, eyeing cancer immunothe...

App helps cancer patients manage their meds

World ADC London 2020

FDA grants AZ's Imfinzi fast review in new lung cancer use

Merck & Co's Keytruda shows promise with prostate cancer 'su...

Conservatives shy away from drug price debate in election ma...

The long-delayed promise of the microbiome, with Sam Possemi...

How to meet your physicians where they are online

Cancer

Editor's Picks